marginally significantp <0.07
The VIF of on‐treatment cumulative systolic BP reduction was marginally significant ( p <0.07) and trended lower under benazepril/amlodipine (−35%), whereas residual BPV did not.
The VIF of on‐treatment cumulative systolic BP reduction was marginally significant ( p <0.07) and trended lower under benazepril/amlodipine (−35%), whereas residual BPV did not.